IP Library Granted Patent US 11,562,823
Granted Patent B2
US 11,562,823 · App. 14/766,138 · Granted Jan 24, 2023

Method and system for remote monitoring of a software medical device

Inventors: Etienne Vial (Levallois Perret, FR); Romain Marmot (Suresnes, FR)
Assignee: VOLUNTIS
G16H40/63G16H40/40G16H40/67
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,562,823
App. No.
14/766,138
Granted
Jan 24, 2023
Kind
B2
Abstract

A method for monitoring a medical device (DM) available to a patient (P), the medical device (DM) including a communication terminal (T) implementing software functionalities (f 1 , f 2 , f 3 ) for accompanying the patient (P) in a predetermined therapeutic treatment, the method including: —a step (S 1 ) of receiving the current data (DC) on execution of the software functionalities (f 1 , f 2 , f 3 ) coming from the medical device (DM), —a step (S 2 ) of testing the current data (DC) by comparison with reference data (DR) according to at least one predetermined vigilance rule (R) associated with a risk for the patient, and —a step (S 3 ) of sending a vigilance message (M 1 ) when such a risk is identified.

Claims (35)

1. A method for monitoring a medical device that is available to a patient and is equipped with a communication terminal that operates in accordance with software functionalities that accompany the patient in a predetermined therapeutic treatment, said method comprising:

receiving, at a monitoring device, current data from the medical device for executing said software functionalities, said current data being generated by the medical device;

testing said current data at the monitoring device by comparing said current data received from the medical device with reference data according to at least one predetermined vigilance rule associated with a risk for the patient, said risk being related to a malfunctioning of a software functionality when executed with said current data, and thereby determining whether there is a presence of said risk, said software functionality being one among the software functionalities,

a determination during the testing of a presence of the risk resulting in automatically sending to said medical device a vigilance message comprising information of said risk determined during the testing together with an instruction that causes deactivation of the malfunctioning software functionality, said deactivation of the malfunctioning software functionality preventing the malfunctioning software functionality from any execution until a corrective event takes place, and

a determination during the testing of no presence of the risk resulting in automatically sending a validation message to the medical device, the validation message comprising an instruction that causes the medical device to keep said software functionality active for a predetermined period of validity,

wherein said software functionality is automatically deactivated at the medical device upon expiration of said predetermined period of validity if no further validation message is received by the medical device during the predetermined period of validity.

2. The method according to claim 1 , wherein the vigilance rule comprises a criterion on compatibility of the software functionalities with a software and/or hardware environment.

3. The method according to claim 1 , wherein the current data comprise information relating to a version of the software functionalities.

4. The method according to claim 1 , wherein the current data comprise information on the computer environment version executing the software functionalities.

5. The method according to claim 1 , wherein the current data comprise information on the model of the communication terminal.

6. The method according to claim 1 , wherein the medical device comprises, in addition to the communication terminal, an auxiliary medical measurement device, and the current data comprise information on the model of the auxiliary device.

7. The method according to claim 1 , wherein the medical device comprises at least one patient activity sensor and an interpretation module that interprets said activity in order to determine an activity data item on the patient, said current data comprising said activity data item on the patient.

8. A non-transitory computer-readable storage medium having recorded thereon a computer program comprising one or more sequences of instructions executable by a processor of a monitoring device,

wherein, upon execution of said computer program by said processor, said program implements a monitoring method for monitoring a medical device available to a patient, said medical device equipped with a communication terminal that operates software functionalities that accompany the patient in a predetermined therapeutic treatment, and

wherein said monitoring method comprises:

receiving current data from the medical device for executing said software functionalities, said current data being generated by the medical device,

testing said current data received from the medical device by comparing said current data with reference data according to at least one predetermined vigilance rule associated with a risk for the patient, said risk being related to a malfunctioning of a software functionality when executed with said current data, and thereby determining whether there is a presence of said risk, said software functionality being one among the software functionalities,

a determination during the testing of a presence of the risk resulting in automatically sending to said medical device a vigilance message comprising information of said risk determined during the testing together with an instruction that causes deactivation of the malfunctioning software functionality, said deactivation of the malfunctioning software functionality preventing the malfunctioning software functionality from any execution until a corrective event takes place, and

a determination during the testing of no presence of the risk resulting in automatically sending a validation message to the medical device, the validation message comprising an instruction that causes the medical device to keep said software functionality active for a predetermined period of validity,

said software functionality being automatically deactivated at the medical device upon expiration of said predetermined period of validity if no further validation message is sent to the medical device during the predetermined period of validity.

9. A system for monitoring a medical device available to a patient, said medical device comprising:

a communication terminal that operates in accordance with software functionalities that accompany the patient in a predetermined therapeutic treatment,

wherein said monitoring system comprises:

a receiver configured to receive from the medical device current data for execution of said software functionalities,

a test circuit configured to compare said current data received from the medical device with reference data according to at least one predetermined vigilance rule associated with a risk for the patient, said risk being related to a malfunctioning of a software functionality when executed with said current data, and thereby determine whether there is a presence of said risk, said software functionality being one among the software functionalities, and

a transmitter configured to, responsive to a determination during the testing of a presence of the risk, automatically send to said medical device a vigilance message comprising information of the risk determined during the testing together with an instruction that causes deactivation of the malfunctioning software functionality, said deactivation of the malfunctioning software functionality preventing the malfunctioning software functionality from any execution until a corrective event takes place and to, responsive to a determining during the testing of no presence of the risk, send a validation message to the medical device, the validation message comprising an instruction that causes the medical device to keep said software functionality active for a predetermined period of validity, wherein said software functionality is automatically deactivated at the medical device upon expiration of said predetermined period of validity if no further validation message is sent to the medical device during the predetermined period of validity.

10. A computer server that monitors a medical device available to a patient, said computer server comprising a monitoring system according to claim 9 .

11. A medical device available to a patient, comprising:

a communication terminal implementing software functionalities that accompanies the patient in a predetermined therapeutic treatment,

a transmitter,

a monitoring system according to claim 9 , and

a vigilance safety that automatically deactivates at least one software functionality on reception of a vigilance message sent when a risk has been identified by the monitoring system, said vigilance message comprising an instruction for deactivating said at least one software functionality,

wherein said transmitter automatically transmits current data on execution of said software functionalities to said monitoring system.

12. The medical device according to claim 11 , wherein the transmitter transmits the current data periodically.

13. The medical device according to claim 12 , wherein the vigilance safety automatically deactivates at least one software functionality when no validation message has been received during a predetermined period.

Assignments (3)
RELEASE OF PLEDGE Recorded Sep 28, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: VOLUNTIS S.A.
Reel/Frame 057631/0196 →
SECURITY INTEREST Recorded Nov 20, 2018
From: VOLUNTIS S.A.
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 047554/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2015
From: VIAL, ETIENNE; MARMOT, ROMAIN
To: VOLUNTIS
Reel/Frame 036263/0842 →
Priority Claims (1)
FR 13 51333 · Feb 15, 2013 · national
Continuity (1)
Related Publication 20150370983A1 · Dec 24, 2015